Literature DB >> 31632793

Expanding the donor pool for lung transplantation using HCV-positive donors.

Hrishikesh S Kulkarni1, Kevin M Korenblat2, Daniel Kreisel3.   

Abstract

Entities:  

Year:  2019        PMID： 31632793      PMCID： PMC6783764          DOI： 10.21037/jtd.2019.08.27

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

Review 1.  Is prevention the best treatment? CMV after lung transplantation.

Authors:  N Patel; L D Snyder; A Finlen-Copeland; S M Palmer
Journal:  Am J Transplant       Date:  2011-11-09       Impact factor: 8.086

Review 2.  Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis c in the era of new oral direct-acting antivirals: A concise review.

Authors:  Sarah V Burgess; Trana Hussaini; Eric M Yoshida
Journal:  Ann Hepatol       Date:  2016 Mar-Apr       Impact factor: 2.400

3.  Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.

Authors:  Ann E Woolley; Steve K Singh; Hilary J Goldberg; Hari R Mallidi; Michael M Givertz; Mandeep R Mehra; Antonio Coppolino; Amanda E Kusztos; Megan E Johnson; Kaiwen Chen; Esther A Haddad; John Fanikos; David P Harrington; Phillip C Camp; Lindsey R Baden
Journal:  N Engl J Med       Date:  2019-04-03       Impact factor: 91.245

Review 4.  Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation.

Authors:  David R Snydman; Ajit P Limaye; Luciano Potena; Martin R Zamora
Journal:  Transplant Proc       Date:  2011-04       Impact factor: 1.066

5.  Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients.

Authors:  Josh Levitsky; Elizabeth C Verna; Jacqueline G O'Leary; Natalie H Bzowej; Dilip K Moonka; Robert H Hyland; Sarah Arterburn; Hadas Dvory-Sobol; Diana M Brainard; John G McHutchison; Norah A Terrault
Journal:  N Engl J Med       Date:  2016-11-24       Impact factor: 91.245

6.  Geographic disparities in donor lung supply and lung transplant waitlist outcomes: A cohort study.

Authors:  Luke J Benvenuto; David R Anderson; Hanyoung P Kim; Jaime L Hook; Lori Shah; Hilary Y Robbins; Frank D'Ovidio; Matthew Bacchetta; Joshua R Sonett; Selim M Arcasoy
Journal:  Am J Transplant       Date:  2018-01-27       Impact factor: 8.086

Review 7.  Moving from the HIV Organ Policy Equity Act to HIV Organ Policy Equity in action: changing practice and challenging stigma.

Authors:  Brianna L Doby; Aaron A R Tobian; Dorry L Segev; Christine M Durand
Journal:  Curr Opin Organ Transplant       Date:  2018-04       Impact factor: 2.640

8.  Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study.

Authors:  Victor Monforte; Helena Sintes; Cristina López-Gallo; Maria Delgado; Francisco Santos; Felipe Zurbano; Amparo Solé; Joan Gavaldá; Jose Maria Borro; Javier Redel-Montero; Jose Manuel Cifrian; Amparo Pastor; Antonio Román; Piedad Ussetti
Journal:  Transpl Infect Dis       Date:  2017-05-09       Impact factor: 2.228

9.  Continued Successful Evolution of Extended Criteria Donor Lungs for Transplantation.

Authors:  Sakhee Kotecha; Jamie Hobson; Jeremy Fuller; Eldho Paul; Bronwyn J Levvey; Helen Whitford; Miranda Paraskeva; David McGiffin; Gregory I Snell; Glen P Westall
Journal:  Ann Thorac Surg       Date:  2017-09-28       Impact factor: 4.330

10.  Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.

Authors:  Christine M Durand; Mary G Bowring; Diane M Brown; Michael A Chattergoon; Guido Massaccesi; Nichole Bair; Russell Wesson; Ashraf Reyad; Fizza F Naqvi; Darin Ostrander; Jeremy Sugarman; Dorry L Segev; Mark Sulkowski; Niraj M Desai
Journal:  Ann Intern Med       Date:  2018-03-06       Impact factor: 51.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.